What is a tumor marker for mature cystic teratoma (MCT)?

Updated: Nov 22, 2019
  • Author: Chad A Hamilton, MD; Chief Editor: Yukio Sonoda, MD  more...
  • Print

Tumor markers, such as squamous cell carcinoma (SCC) antigen, are useful for identifying the presence of SCC arising from mature cystic teratoma (MCT), but no set cut-off level has been established. Choi et al reported elevated SCC antigen levels ranging from 1.5 ng/mL in International Federation of Gynecology and Obstetrics (FIGO) stage Ia tumors to 11.3 ng/mL in stage IIIc in four patients with confirmed SCC arising from MCT. [42]  

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!